titanium has been researched along with irinotecan in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (33.33) | 29.6817 |
2010's | 3 (50.00) | 24.3611 |
2020's | 1 (16.67) | 2.80 |
Authors | Studies |
---|---|
Kinoshita, H; Kitaura, T; Nakae, S; Onoyama, H; Sainoh, K; Saitoh, Y; Shiroiwa, H; Sugihara, S; Takahashi, T; Takao, S; Toyota, J; Urakawa, T; Yamamoto, M | 1 |
Aizawa, M; Ishibashi, K; Itagaki, H; Katsube, T; Kobayashi, R; Naritaka, Y; Ogawa, K; Yokomizo, H; Yoshimatsu, K | 1 |
Goto, S; Kamigaki, T; Saito, M; Yano, K | 1 |
Chen, Y; Gong, S; Li, N; Pan, W; Tang, B; Wang, J; Yu, L | 1 |
Ao, Y; Liu, Y; Tong, L; Yu, T; Zhang, G; Zhang, H | 1 |
6 other study(ies) available for titanium and irinotecan
Article | Year |
---|---|
[A patient with peritoneal metastasis from gastric cancer who responded to weekly chemotherapy with paclitaxel on the third line and could take meal].
Topics: Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Camptothecin; Humans; Irinotecan; Male; Middle Aged; Paclitaxel; Peritoneal Neoplasms; Silicates; Stomach Neoplasms; Titanium | 2003 |
[Host immunity in colorectal cancer patients treated with TS-1 plus CPT-11].
Topics: Aged; Antineoplastic Agents, Phytogenic; Camptothecin; Colorectal Neoplasms; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Irinotecan; Silicates; Titanium | 2005 |
A patient with scirrhous stomach cancer treated with combination of hyperthermotherapy and 5-aminolevulinic acid (ALA).
Topics: Adenocarcinoma, Scirrhous; Adult; Aminolevulinic Acid; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoma, Signet Ring Cell; Cisplatin; Combined Modality Therapy; Dichloroacetic Acid; Docetaxel; Drug Combinations; Drug Therapy, Combination; Female; Humans; Hyperthermia, Induced; Irinotecan; Ovarian Neoplasms; Oxonic Acid; Paclitaxel; Peritoneal Neoplasms; Photosensitizing Agents; Prognosis; Silicates; Stomach Neoplasms; Taxoids; Tegafur; Titanium | 2013 |
Singapore Cancer Network (SCAN) Guidelines for Systemic Therapy of Pancreatic Adenocarcinoma.
Topics: Adenocarcinoma; Albumins; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Camptothecin; Carcinoma, Pancreatic Ductal; Cetuximab; Chemoradiotherapy, Adjuvant; Chemotherapy, Adjuvant; Deoxycytidine; Fluorouracil; Gemcitabine; Humans; Irinotecan; Leucovorin; Neoadjuvant Therapy; Organoplatinum Compounds; Oxaliplatin; Paclitaxel; Pancreatic Neoplasms; Silicates; Singapore; Titanium | 2015 |
A nuclear-targeted titanium dioxide radiosensitizer for cell cycle regulation and enhanced radiotherapy.
Topics: Cell Cycle; Cell Line, Tumor; Cell Nucleus; Humans; Irinotecan; Metal Nanoparticles; Microscopy, Electron, Transmission; Oligopeptides; Radiation-Sensitizing Agents; Radiotherapy; Reactive Oxygen Species; Titanium; Topoisomerase I Inhibitors; X-Rays | 2019 |
NIR triggered PLGA coated Au-TiO
Topics: Biocompatible Materials; Cell Line, Tumor; Cell Survival; Drug Carriers; Drug Delivery Systems; Humans; Irinotecan; Metal Nanoparticles; Polylactic Acid-Polyglycolic Acid Copolymer; Thyroid Cancer, Papillary; Titanium; Topoisomerase I Inhibitors; Treatment Outcome | 2020 |